Prolonged vs short-term infusion of β-lactam antibiotics for the treatment of febrile neutropenia: A systematic review and meta-analysis - 05/08/23
, M. Ulldemolins a, M. Puig-Asensio a, c, C. Tebé d, S. Castro a, J. Carratalà a, c, e, C. Gudiol a, b, c, eSummary |
Background |
The optimisation of the use of β-lactam antibiotics (BLA) via prolonged infusions in life-threatening complications such as febrile neutropenia (FN) is still controversial. This systematic review and meta-analysis aim to evaluate the efficacy of this strategy in onco-haematological patients with FN.
Methods |
A systematic search was performed of PubMed, Web of Science, Cochrane, EMBASE, World Health Organization, and ClinicalTrials.gov, from database inception until December 2022. The search included randomised controlled trials (RCTs) and observational studies that compared prolonged vs short-term infusions of the same BLA. The primary outcome was all-cause mortality. Secondary outcomes were defervescence, requirement of vasoactive drugs, length of hospital stay and adverse events. Pooled risk ratios were calculated using random effects models.
Results |
Five studies were included, comprising 691 episodes of FN, mainly in haematological patients. Prolonged infusion was not associated with a reduction in all-cause mortality (pRR 0.83; 95% confidence interval 0.47–1.48). Nor differences were found in secondary outcomes.
Conclusions |
The limited data available did not show significant differences in terms of all-cause mortality or significant secondary outcomes in patients with FN receiving BLA in prolonged vs. short-term infusion. High-quality RCTs are needed to determine whether there are subgroups of FN patients who would benefit from prolonged BLA infusion.
Le texte complet de cet article est disponible en PDF.Keywords : Febrile neutropenia, β-lactam antibiotics, Prolonged infusion, Extended infusion, Continuous infusion, Short-term infusion, Intermittent infusion, Systematic review, Meta-analysis, Mortality
Plan
Vol 87 - N° 3
P. 190-198 - septembre 2023 Retour au numéro
Article précédent
- Global treatment outcomes of extensively drug-resistant tuberculosis in adults: A systematic review and meta-analysis
- Ole Skouvig Pedersen, Freja Breth Holmgaard, Mads Kristian Duborg Mikkelsen, Christoph Lange, Giovanni Sotgiu, Troels Lillebaek, Aase Bengaard Andersen, Christian Morberg Wejse, Victor Naestholt Dahl
- Faecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in a remote region of Niger
- Hervé Jacquier, Bachir Assao, Françoise Chau, Ousmane Guindo, Bénédicte Condamine, Mélanie Magnan, Antoine Bridier-Nahmias, Nathan Sayingoza-Makombe, Aissatou Moumouni, Anne-Laure Page, Céline Langendorf, Matthew E. Coldiron, Erick Denamur, Victoire de Lastours
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?